T1	PROC 44 60	Estudio Fase III
T2	CHEM 339 350	ETROLIZUMAB
#1	AnnotatorNotes T2	C3177463; etrolizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	PROC 95 106	tratamiento
#2	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	DISO 142 161	enfermedad de Crohn
#3	AnnotatorNotes T4	C0010346; Crohn Disease; Disease or Syndrome
T5	PROC 210 294	ESTUDIO MULTICÉNTRICO DE FASE III ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO
T6	PROC 300 334	EVALUAR LA EFICACIA Y LA SEGURIDAD
#4	AnnotatorNotes T6	C0511730; Identify product efficacy and safety issues; Health Care Activity
T7	PROC 356 396	TRATAMIENTO DE INDUCCIÓN Y MANTENIMIENTO
#5	AnnotatorNotes T7	C0677908; Maintenance therapy; Therapeutic or Preventive Procedure + C0857127; Induction procedure; Therapeutic or Preventive Procedure
T8	DISO 414 433	ENFERMEDAD DE CROHN
#6	AnnotatorNotes T8	C0010346; Crohn Disease; Disease or Syndrome
T9	DISO 494 528	enfermedad inflamatoria intestinal
#7	AnnotatorNotes T9	C0021390; Inflammatory Bowel Diseases; Disease or Syndrome
T10	DISO 555 574	Enfermedad de Crohn
#8	AnnotatorNotes T10	C0010346; Crohn Disease; Disease or Syndrome
T11	DISO 643 662	Enfermedad de Crohn
#9	AnnotatorNotes T11	C0010346; Crohn Disease; Disease or Syndrome
T12	ANAT 748 753	colon
#10	AnnotatorNotes T12	C0009368; Colon structure; Body Part, Organ, or Organ Component | C1281569; Entire colon; Body Part, Organ, or Organ Component
T13	PROC 773 783	endoscopia
#11	AnnotatorNotes T13	C0014245; Endoscopy (procedure); Diagnostic Procedure
T14	CHEM 843 859	corticosteroides
#12	AnnotatorNotes T14	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T15	CHEM 884 886	ID
#13	AnnotatorNotes T15	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T16	CHEM 866 882	inmunodepresores
#14	AnnotatorNotes T16	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T17	ANAT 736 741	íleón
T18	CHEM 890 909	inhibidores del TNF
T19	CHEM 958 973	anticonceptivos
#15	AnnotatorNotes T19	C0009871; Contraceptive Agents; Pharmacologic Substance
T20	PROC 1008 1017	protocolo
#16	AnnotatorNotes T20	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T21	ANAT 1106 1120	tubo digestivo
#17	AnnotatorNotes T21	C0017189; Gastrointestinal tract structure; Body System | C4516948; Entire digestive tract; Body System
T22	DISO 1133 1149	colitis ulcerosa
#18	AnnotatorNotes T22	C0009324; Ulcerative Colitis; Disease or Syndrome
T23	DISO 1153 1174	colitis indeterminada
#19	AnnotatorNotes T23	C0341332; Indeterminate colitis; Disease or Syndrome
T24	DISO 1176 1184	fístulas
#20	AnnotatorNotes T24	C0016169; pathologic fistula; Anatomical Abnormality
T25	DISO 1198 1226	absceso abdominal o perianal
T26	ANAT 1218 1226	perianal
#21	AnnotatorNotes T26	C0442158; Perianal; Body Location or Region
T27	DISO 1228 1258	pólipos colónicos adenomatosos
T28	DISO 1260 1291	displasia en la mucosa colónica
T29	ANAT 1276 1291	mucosa colónica
#22	AnnotatorNotes T29	C1284432; Entire colonic mucous membrane; Tissue
T30	DISO 1295 1323	síndrome del intestino corto
#23	AnnotatorNotes T30	C0036992; Short Bowel Syndrome; Disease or Syndrome
T31	PROC 1356 1363	cirugía
#24	AnnotatorNotes T31	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T32	DISO 1376 1390	complicaciones
#25	AnnotatorNotes T32	C0009566; Complication; Pathologic Function
T33	DISO 1411 1413	EC
#26	AnnotatorNotes T33	C0010346; Crohn Disease; Disease or Syndrome
T34	PROC 1417 1427	Ileostomía
#27	AnnotatorNotes T34	C0020883; Creation of ileostomy; Therapeutic or Preventive Procedure
T35	PROC 1369 1375	tratar
#28	AnnotatorNotes T35	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T36	PROC 1459 1471	tratamientos
#29	AnnotatorNotes T36	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T37	DISO 1494 1528	enfermedad inflamatoria intestinal
#30	AnnotatorNotes T37	C0021390; Inflammatory Bowel Diseases; Disease or Syndrome
T38	DISO 1530 1533	EII
#31	AnnotatorNotes T38	C0021390; Inflammatory Bowel Diseases; Disease or Syndrome
T39	CHEM 1546 1557	vedolizumab
#32	AnnotatorNotes T39	C2742797; vedolizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T40	CHEM 1559 1570	natalizumab
#33	AnnotatorNotes T40	C1172734; natalizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T41	CHEM 1573 1583	efalizumab
#34	AnnotatorNotes T41	C1174995; efalizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T42	PROC 1610 1619	protocolo
#35	AnnotatorNotes T42	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T43	DISO 1623 1660	Infección crónica por Hepatitis B o C
T44	DISO 1667 1709	infección activa o latente de tuberculosis
T45	PROC 1745 1755	vacunación
#36	AnnotatorNotes T45	C0042196; Vaccination; Therapeutic or Preventive Procedure
T46	CHEM 1763 1788	bacilo de Calmette-Guérin
#37	AnnotatorNotes T46	C0004886; BCG Vaccine; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T47	PROC 1824 1833	screening
#38	AnnotatorNotes T47	C0220908; Screening procedure; Diagnostic Procedure
T48	PROC 1850 1859	protocolo
#39	AnnotatorNotes T48	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T49	CHEM 77 88	etrolizumab
#40	AnnotatorNotes T49	C3177463; etrolizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T50	ANAT 518 528	intestinal
#41	AnnotatorNotes T50	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T51	DISO 721 753	afectación del íleón o del colon
T52	Observation 801 812	resistencia
#42	AnnotatorNotes T52	C3542449; Drug Resistance Status; Finding
T53	DISO 787 799	Intolerancia
#43	AnnotatorNotes T53	C0277585; Intolerance to drug; Pathologic Function
T54	CHEM 861 863	CE
#44	AnnotatorNotes T54	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T55	ANAT 1206 1215	abdominal
#45	AnnotatorNotes T55	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T56	ANAT 1236 1245	colónicos
#46	AnnotatorNotes T56	C0009368; Colon structure; Body Part, Organ, or Organ Component | C1281569; Entire colon; Body Part, Organ, or Organ Component
T57	ANAT 1308 1317	intestino
#47	AnnotatorNotes T57	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T58	PROC 1430 1440	colostomía
#48	AnnotatorNotes T58	C0009410; Colostomy Procedure; Therapeutic or Preventive Procedure
T59	ANAT 1518 1528	intestinal
#49	AnnotatorNotes T59	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T60	DISO 1662 1665	VIH
#50	AnnotatorNotes T60	C0458074; Human immunodeficiency virus (HIV) status; Finding
T61	Date 12 16	2014
T63	LIVB 128 137	pacientes
#51	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	LIVB 400 409	PACIENTES
#52	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T65	Age 609 627	entre 18 y 80 años
T68	Duration 920 938	los 5 años previos
T69	Spec_cue 1186 1197	Indicios de
T71	Duration 1633 1640	crónica
#53	AnnotatorNotes T71	C0205191; chronic; Temporal Concept
T73	LIVB 1711 1720	pacientes
#54	AnnotatorNotes T73	C0030705; Patients; Patient or Disabled Group
A1	Assertion T25 Speculated
A2	Assertion T36 Contraindicated
A3	Assertion T39 Contraindicated
A4	Assertion T40 Contraindicated
A5	Assertion T41 Contraindicated
A6	Status T45 History_of
A7	Status T46 History_of
A8	Status T22 History_of
A9	Status T23 History_of
A10	Status T24 History_of
A11	Status T25 History_of
A12	Status T27 History_of
A13	Status T28 History_of
A14	Status T30 History_of
A15	Status T36 History_of
A16	Status T58 History_of
A17	Status T34 History_of
A18	Status T39 History_of
A19	Status T40 History_of
A20	Status T41 History_of
#55	AnnotatorNotes T18	C3537192; Tumor Necrosis Factor Inhibitors; Pharmacologic Substance 
#56	AnnotatorNotes T25	C0031019; Perianal abscess; Disease or Syndrome + C0243001; Abdominal Abscess; Disease or Syndrome 
#57	AnnotatorNotes T27	C1868071; Adenomatous colonic polyposis; Finding 
#58	AnnotatorNotes T43	C0524909; Hepatitis B, Chronic; Disease or Syndrome + C0524910; Hepatitis C, Chronic; Disease or Syndrome 
#59	AnnotatorNotes T44	C0151332; Active tuberculosis; Disease or Syndrome + C1609538; Latent Tuberculosis; Disease or Syndrome
T62	Neg_cue 1472 1474	no
T66	Quantifier_or_Qualifier 1475 1485	permitidos
A21	Assertion T66 Negated
#60	AnnotatorNotes T66	C0205540; Approved; Qualitative Concept
T67	Neg_cue 815 826	ausencia de
T70	Observation 827 836	respuesto
A22	Assertion T70 Negated
#61	AnnotatorNotes T70	C4055223; Clinical Response; Finding (?)
T72	Spec_cue 74 76	si
T74	Quantifier_or_Qualifier 107 113	seguro
A23	Assertion T74 Speculated
R1	Speculation Arg1:T72 Arg2:T74	
R2	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T74	
T75	Quantifier_or_Qualifier 116 124	efectivo
#62	AnnotatorNotes T75	C1704419; Effective; Qualitative Concept
R3	Speculation Arg1:T72 Arg2:T75	
R4	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T75	
R5	Experiences Arg1:T63 Arg2:T49	
R6	Used_for Arg1:T49 Arg2:T3	
R7	Experiences Arg1:T63 Arg2:T4	
T76	Quantifier_or_Qualifier 162 168	activa
#63	AnnotatorNotes T76	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R8	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T76	
T77	Quantifier_or_Qualifier 172 188	moderada a grave
#64	AnnotatorNotes T77	C1299393; Moderate to severe; Qualitative Concept
R9	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T77	
T78	Quantifier_or_Qualifier 444 460	MODERADA A GRAVE
#65	AnnotatorNotes T78	C1299393; Moderate to severe; Qualitative Concept
T79	Quantifier_or_Qualifier 673 689	moderada a grave
#66	AnnotatorNotes T79	C1299393; Moderate to severe; Qualitative Concept
R10	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T79	
T80	Quantifier_or_Qualifier 434 440	ACTIVA
#67	AnnotatorNotes T80	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R11	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T80	
R12	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T78	
T81	Quantifier_or_Qualifier 663 669	activa
#68	AnnotatorNotes T81	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R13	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T81	
R14	Used_for Arg1:T2 Arg2:T7	
R15	Experiences Arg1:T64 Arg2:T2	
R16	Experiences Arg1:T64 Arg2:T8	
A24	Assertion T75 Speculated
R17	Location_of Arg1:T50 Arg2:T9	
T82	PROC 711 715	CDAI
#69	AnnotatorNotes T82	C5549856; Assessment using Simple Endoscopic Score for Crohn's Disease; Health Care Activity
R18	Location_of Arg1:T12 Arg2:T51	
#70	AnnotatorNotes T17	C0020885; ileum; Body Part, Organ, or Organ Component | C1278923; Entire ileum; Body Part, Organ, or Organ Component
R19	Location_of Arg1:T17 Arg2:T51	
R20	Causes Arg1:T11 Arg2:T51	
R22	Negation Arg1:T67 Arg2:T70	
R23	Causes Arg1:T14 Arg2:T53	
R24	Causes Arg1:T54 Arg2:T53	
R25	Causes Arg1:T16 Arg2:T53	
R26	Causes Arg1:T15 Arg2:T53	
R27	Causes Arg1:T18 Arg2:T53	
R28	Overlap Arg1:T52 Arg2:T14	
R29	Overlap Arg1:T52 Arg2:T54	
R30	Overlap Arg1:T52 Arg2:T16	
R31	Overlap Arg1:T52 Arg2:T15	
R32	Overlap Arg1:T52 Arg2:T18	
R33	Overlap Arg1:T52 Arg2:T68	
R34	Overlap Arg1:T70 Arg2:T14	
R35	Overlap Arg1:T70 Arg2:T54	
R36	Overlap Arg1:T70 Arg2:T16	
R37	Overlap Arg1:T70 Arg2:T15	
R38	Overlap Arg1:T70 Arg2:T18	
R39	Overlap Arg1:T14 Arg2:T68	
R40	Overlap Arg1:T54 Arg2:T68	
R41	Overlap Arg1:T16 Arg2:T68	
R42	Overlap Arg1:T15 Arg2:T68	
R43	Overlap Arg1:T18 Arg2:T68	
R44	Location_of Arg1:T21 Arg2:T22	
R45	Location_of Arg1:T21 Arg2:T23	
R46	Location_of Arg1:T21 Arg2:T24	
R47	Speculation Arg1:T69 Arg2:T25	
R48	Location_of Arg1:T26 Arg2:T25	
R49	Location_of Arg1:T55 Arg2:T25	
R50	Location_of Arg1:T56 Arg2:T27	
R51	Location_of Arg1:T29 Arg2:T28	
R52	Location_of Arg1:T57 Arg2:T30	
T83	Quantifier_or_Qualifier 1327 1336	Previsión
#71	AnnotatorNotes T83	C1301732; Planned; Functional Concept
R53	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T83	
R54	Causes Arg1:T33 Arg2:T32	
R55	Negation Arg1:T62 Arg2:T66	
R56	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T66	
R57	Location_of Arg1:T59 Arg2:T37	
R58	Location_of Arg1:T59 Arg2:T38	
R59	Used_for Arg1:T39 Arg2:T36	
R60	Used_for Arg1:T40 Arg2:T36	
R61	Used_for Arg1:T41 Arg2:T36	
R62	Has_Duration_or_Interval Arg1:T43 Arg2:T71	
R63	Has_Duration_or_Interval Arg1:T60 Arg2:T71	
R64	Experiences Arg1:T73 Arg2:T45	
R65	Experiences Arg1:T73 Arg2:T47	
R66	Experiences Arg1:T73 Arg2:T43	
R67	Experiences Arg1:T73 Arg2:T60	
R68	Experiences Arg1:T73 Arg2:T44	
R69	Used_for Arg1:T46 Arg2:T45	
#72	AnnotatorNotes T1	C0282461; Phase 3 Clinical Trials; Research Activity
A25	Experiencer T73 Patient
A26	Experiencer T63 Patient
A27	Experiencer T64 Patient
A28	Status T31 Future
